These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2374149)

  • 1. In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
    Rollema H; Johnson EA; Booth RG; Caldera P; Lampen P; Youngster SK; Trevor AJ; Naiman N; Castagnoli N
    J Med Chem; 1990 Aug; 33(8):2221-30. PubMed ID: 2374149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of in vivo brain dialysis of dopamine, acetylcholine, amino acids and lactic acid in studies on the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Rollema H; de Vries JB; Damsma G; Westerink BH; Kranenborg GL; Kuhr WG; Horn AS
    Toxicology; 1988 May; 49(2-3):503-11. PubMed ID: 3259743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
    J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
    Booth RG; Castagnoli N; Rollema H
    Neurosci Lett; 1989 May; 100(1-3):306-12. PubMed ID: 2788253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP.
    Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM
    Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
    Zuddas A; Corsini GU; Schinelli S; Barker JL; Kopin IJ; di Porzio U
    Brain Res; 1989 Oct; 501(1):11-22. PubMed ID: 2804689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
    Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
    Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    Giovanni A; Sonsalla PK; Heikkila RE
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1008-14. PubMed ID: 7932148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new in vitro approach for investigating the MPTP effect on DA uptake.
    Barc S; Page G; Fauconneau B; Barrier L; Huguet F
    Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Caliguri EJ; Johannessen JN
    Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN; Sobotka TJ; Weise VK; Markey SP
    J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP, MPP+ and mitochondrial function.
    Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
    Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
    Rollema H; De Vries JB; Westerink BH; Van Putten FM; Horn AS
    Eur J Pharmacol; 1986 Dec; 132(1):65-9. PubMed ID: 3102260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mitochondrial respiration by analogues of the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium: structural requirements for accumulation-dependent enhanced inhibitory potency on intact mitochondria.
    Sayre LM; Singh MP; Arora PK; Wang F; McPeak RJ; Hoppel CL
    Arch Biochem Biophys; 1990 Aug; 280(2):274-83. PubMed ID: 2369119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.